Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma
Susan E. Abbatiello, Birgit Schilling, D.R. Mani et al. · Molecular & Cellular Proteomics · 2015
There is an increasing need in biology and clinical medicine to robustly and reliably measure tens to hundreds of peptides and proteins in clinical and biological samples with high sensitivity, specificity, reproducibility, and repeatability. Previously, we demonstrated that LC-MRM-MS with isotope dilution has suitable performance for quantitative measurements of small numbers of relatively abundant proteins in human plasma and that the resulting assays can be transferred across laboratories while maintaining high reproducibility and quantitative precision. Here, we significantly extend that earlier work, demonstrating that 11 laboratories using 14 LC-MS systems can develop, determine analytical figures of merit, and apply highly multiplexed MRM-MS assays targeting 125 peptides derived from 27 cancer-relevant proteins and seven control proteins to precisely and reproducibly measure the analytes in human plasma. To ensure consistent generation of high quality data, we incorporated a system suitability protocol (SSP) into our experimental design. The SSP enabled real-time monitoring of LC-MRM-MS performance during assay development and implementation, facilitating early detection and correction of chromatographic and instrumental problems. Low to subnanogram/ml sensitivity for proteins in plasma was achieved by one-step immunoaffinity depletion of 14 abundant plasma proteins prior to analysis. Median intra- and interlaboratory reproducibility was <20%, sufficient for most biological studies and candidate protein biomarker verification. Digestion recovery of peptides was assessed and quantitative accuracy improved using heavy-isotope-labeled versions of the proteins as internal standards. Using the highly multiplexed assay, participating laboratories were able to precisely and reproducibly determine the levels of a series of analytes in blinded samples used to simulate an interlaboratory clinical study of patient samples. Our study further establishes that LC-MRM-MS using stable isotope dilution, with appropriate attention to analytical validation and appropriate quality control measures, enables sensitive, specific, reproducible, and quantitative measurements of proteins and peptides in complex biological matrices such as plasma.
Cited by 214 works. doi:10.1074/mcp.m114.047050 Open-access PDF
Authors
- Susan E. Abbatiello
- Birgit Schilling
- D.R. Mani
- Lisa J. Zimmerman
- Steven C. Hall
- Brendan MacLean
- Matthew E. Albertolle
- Simon Allen
- Michael W. Burgess
- Michael P. Cusack
- Victoria Hedrick
- Jason M. Held
- Halina D. Inerowicz
- Angela Jackson
- Hasmik Keshishian
- Christopher R. Kinsinger
- John Sverre Lyssand
- Lee Makowski
- Mehdi Mesri
References
- Limits for qualitative detection and quantitative determination. Application to radiochemistry
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
- Limit of blank, limit of detection and limit of quantitation.
- Protein biomarker discovery and validation: the long and uncertain path to clinical utility
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins
- Mass Spectrometric Quantitation of Peptides and Proteins Using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA)
- Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions